JPRN-UMIN000018879已完成2 期
Efficacy and safety of live varicella vaccine in patients with diabetes mellitus associated with decreased cell-mediated immunity: a Randomized, Double-blind, Placebo-controlled Trial - Efficacy and safety of live varicella vaccine in patients with diabetes: a Randomized, Double-blind, Placebo-controlled Trial
Kitano hospital, The Tazuke Kofukai Medical Research Institute0 个研究点目标入组 80 人开始时间: 2015年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Excluded were users of steroids or other immunosuppressive drugs, those with heart disease treated by antiplatelet drugs, immunocompromised patients with any potential malignant disease, autoimmune disease, renal failure, patients with immunization of varicella vaccine within 5 years, HZ patients, andsmokers,
研究者
相似试验
招募中
不适用
Safety and efficacy of live attenuated varicella vaccine for preventing varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation: A Prospective Single-Center StudyZosterJPRN-UMIN000013799Division of Hematology, Saitama Medical Center, Jichi Medical University31
已完成
1 期
Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy AdultsVaricella (Chicken Pox)NCT02367638Green Cross Corporation39
招募中
Unknown
Investigation of varicella-zoster vaccine immunogenicity according to frailty statusKCT0009555Seoul National University Bundang Hospital100
已完成
Unknown
Clinical study on VARICELLA VACCINE LIVE ATTENUATED BIKEN in subjects aged 50 years or older with underlying disease which influences on the immune systemJPRN-jRCT1080223360The Research Foundation for Microbial Diseases of Osaka University, SOUSEIKAI1,500
进行中（未招募）
1 期
Safety and efficiacy of a new chickenpox and shingles vaccine in patients who have undergone kidney transplantatioEUCTR2019-002529-31-NOOslo University Hospital50